Just a thought
I spoke about your service with Jennifer who fully explained
Response: Regarding commenters' requests for exclusion criteria, we note that the measure methodology, including consideration of potential exclusions, was informed by extensive literature review, empiric analyses, and feedback from the TEP, PFE Work Group, and the public comment period held during measure development
But emideltide, under consideration for opioid withdrawal, chronic insomnia, and narcolepsy, failed voting passage by a tally of 6-7
If company history, manufacturing standards, and industry reputation factor into your decision-making alongside product-specific claims, that longevity is relevant